Chenying Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
-
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Jiansong Ji (43 shared papers)Yongzhong Du (15 shared papers)Gaofeng Shu (15 shared papers)Min Xu (15 shared papers)Bufu Tang (9 shared papers)Shiji Fang (17 shared papers)Qiaoyou Weng (15 shared papers)Jinyu Zhu (6 shared papers)
- Journals
- ACS Applied Materials & Interfaces (4 papers)Scientific Reports (3 papers)Academic Radiology (3 papers)Asian Journal of Pharmaceutical Sciences (2 papers)Journal of Nanobiotechnology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Chenying Lu
66 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 247
- Biomaterials 230
- Pulmonary and Respiratory Medicine 342
- Hepatology 58
- Biomedical Engineering 345
Countries citing papers authored by Chenying Lu
This map shows the geographic impact of Chenying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenying Lu more than expected).
Fields of papers citing papers by Chenying Lu
This network shows the impact of papers produced by Chenying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenying Lu. The network helps show where Chenying Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenying Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 177 | |
| 2 | 2020 | 103 | |
| 3 | 2021 | 99 | |
| 4 | 2021 | 76 | |
| 5 | 2021 | 65 | |
| 6 | 2019 | 65 | |
| 7 | 2020 | 50 | |
| 8 | 2022 | 48 | |
| 9 | 2012 | 45 | |
| 10 | 2023 | 44 | |
| 11 | 2016 | 38 | |
| 12 | 2018 | 38 | |
| 13 | 2020 | 34 | |
| 14 | 2022 | 32 | |
| 15 | 2017 | 31 | |
| 16 | 2014 | 29 | |
| 17 | 2020 | 28 | |
| 18 | 2022 | 27 | |
| 19 | 2021 | 26 | |
| 20 | 2018 | 26 |
About Chenying Lu
Chenying Lu is a scholar working on Biomaterials, Cancer Research, Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Nanoparticle-Based Drug Delivery (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Immune cells in cancer (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). The work is most often cited by research in Cancer Research (247 citations), Biomaterials (230 citations), Pulmonary and Respiratory Medicine (342 citations), Hepatology (58 citations) and Biomedical Engineering (345 citations). Chenying Lu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jiansong Ji, Yongzhong Du, Gaofeng Shu, Min Xu, Bufu Tang, Shiji Fang, Qiaoyou Weng, Jinyu Zhu, Minjiang Chen and Liyun Zheng. Their work appears in journals such as ACS Applied Materials & Interfaces, Scientific Reports, Academic Radiology, Asian Journal of Pharmaceutical Sciences and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.